Rhonda Patrick· PhD
There have been a couple of clinical trials, both involving prostate cancer, investigating the effects of the active compound sulfurophane
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
There have been a couple of clinical trials, both involving prostate cancer, investigating the effects of the active compound sulfurophane
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
We know this from human studies where humans that already have cancer and then are given sulfurophane. It lowers biomarkers of cancer progression. We also know this from animal studies in which animals were given a carcinogen that causes cancer along with sulfurophane and the sulfurophane prevented the cancer from forming.
There's a lot of preclinical evidence out there on sulforaphane protecting against cancer whether it's prostate cancer, breast cancer, colon cancer. I mean it just you go into the literature preclinical data is endless very clear you it's like you can't you can't argue that sulforaphane basically is lowering metastasis it's lowering tumor burden.